Key facts
- This page summarizes Maria S. Rutledge's Form 4 filing for Beneficient (BENF).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Sep 2024, 18:03.
Maria S. Rutledge - 20 Sep 2024 Form 4 Insider Report for Beneficient (BENF)
- Reporting relationship
- Chief Technology Officer
- Issuer ticker
- BENF
- Reported as of
- 20 Sep 2024
- Net transaction value
- +$999
- SEC form
- 4
- Accepted by SEC
- 27 Sep 2024, 18:03:41 UTC
- Prior SEC filing
- 11 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David B. Rost Attorney-in-fact for Maria S. Rutledge
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Maria S. Rutledge filed Form 4 for Beneficient (BENF) on 27 Sep 2024.
Change
- Previous filing in this sequence was filed on 11 Jun 2024.
- Current net transaction value: +$999.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BENF
transaction
Class A Common Stock
Purchase
- Transaction value
- $999
- Shares
- +900
- Change %
- +55%
- Price
- $1.11
- Shares after
- 2,540
- Date
- 20 Sep 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
The shares shown have been retroactively adjusted to reflect Beneficient's (the "Issuer") reverse stock split of its outstanding shares of Class A common stock, par value $0.001 per share ("Class A common stock"), and Class B common stock, par value $0.001 per share, on a 1-for-80 basis effected on April 18, 2024.
Footnote F2
Represents shares of Class A common stock purchased by the Reporting Person's spouse.
Footnote F3
Includes 482 shares of Class A common stock issuable upon the settlement of an award of 482 restricted stock units ("RSUs") granted pursuant to Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to the Reporting Person on July 15, 2023. Such award of RSUs to the Reporting Person vested 20% on September 1, 2023, and the remaining 80% in four equal annual installments on September 1st of each subsequent calendar year.
Footnote F4
Includes 1,094 shares of Class A common stock of the Issuer issuable upon the settlement of an award of 875 restricted equity units ("REUs") granted pursuant to The Beneficient Company Group, L.P. 2018 Equity Incentive Plan ("2018 Equity Incentive Plan") to the Reporting Person on January 1, 2020. Such award of REUs to the Reporting Person vested 40% on the date of grant, and the remaining 60% in three equal annual installments on August 14th of each subsequent calendar year.
Footnote F5
Includes 102 shares of Class A common stock issuable upon settlement of an award of 81 REUs to the Reporting Person granted pursuant to the 2018 Equity Incentive Plan on April 1, 2022. Such award of REUs to the Reporting Person shall vest 40% on June 8, 2023, and the remaining 60% in three equal annual installments on April 1st of each subsequent calendar year.
Footnote F6
Includes 386 shares of Class A common stock of the Issuer issuable upon the settlement of an award of 386 RSUs granted pursuant to 2023 Equity Incentive Plan to the Reporting Person on July 15, 2023. Such award of RSUs to the Reporting Person fully vested on September 1, 2023.